ST-segment Elevation Myocardial Infarction (STEMI) Clinical Trial
Official title:
The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction
Verified date | April 2024 |
Source | RenJi Hospital |
Contact | Jun PU, MD |
Phone | 13817577592 |
pujun310[@]hotmail.com | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients
Status | Not yet recruiting |
Enrollment | 201 |
Est. completion date | July 30, 2028 |
Est. primary completion date | April 30, 2028 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 17 Years to 75 Years |
Eligibility | Inclusion Criteria: - Between 18 and 75-years-old; - Typical symptoms of acute myocardial infarction within 24 hours, with ST segment elevation of =1mm in two consecutive leads on electrocardiogram - After receiving complete revascularization treatment - Cardiac function grading I to II without any other serious complications - Left ventricular ejection fraction >30% - Compliant with the guidelines of the American College of Cardiology/American Heart Association for participating in cardiac rehabilitation standards - Signed written informed consent. Exclusion Criteria: - Patients with unstable angina - severe symptomatic congestive heart failure detectable myocardial ischemia - valvular disease requiring surgery - severe ventricular arrhythmias - severe concomitant life-threatening diseases such as cancer, and rheumatoid disease - osteoarticular diseases that may affect the exercise process |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
RenJi Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | left ventricle ejection fraction | Use cardiac ultrasound system to measure left ventricle ejection fraction | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Oxygen consumption | Patients will be submitted to cardiopulmonary exercise testing on a bicycle, using the modified Bruce protocol. Expired gases will be continuously collected throughout exercise and analyzed for ventilatory volume (VE) and for oxygen (O2) and carbon dioxide (CO2) content, using dedicated analyzers. The investigators will assess exercise capacity mainly by measuring anaerobic threshold oxygen consumption and peak oxygen consumption. | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Endothelial Function | Use high-resolution Doppler duplex ultrasound e equipment to analysis Baseline arterial diameter (mm), peak arterial diameter (mm). | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Skeletal muscle and fat mass | Determined by multifrequency BIA using an InBody 770 analyzer (InBody Co., Ltd), that estimate skeletal muscle mass, Body fat mass, distribution of lean body mass and ratio of segmental lean mass. | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Cardiac structure | Use cardiac ultrasound system to measure left ventricular end-diastolic/end-systolic internal diameter, and left ventricular anterior wall thickness. | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | One year major Adverse Cardiovascular Events | All patients were followed to major adverse cardiovascular events occurred. The investigators observed the incidence of major adverse cardiovascular events during follow-up, including recurrent myocardial infarction, new heart failure, intractable angina and cardiac death. | From baseline to one year after participating in rehabilitation | |
Secondary | VE/VCO2-SLOPE | Patients will be submitted to cardiopulmonary exercise testing on a bicycle, using the modified Bruce protocol. Expired gases will be continuously collected throughout exercise and analyzed for ventilatory volume (VE) and for oxygen (O2) and carbon dioxide (CO2) content, using dedicated analyzers. The VE/VCO2-SLOPE will be collected. | at baseline,at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Flow-mediated dilation | Use high-resolution Doppler duplex ultrasound e equipment to analysis FMD (%)-formula (peak diameter-baseline diameter) / (baseline diameter) *100. | at baseline, at the sixth week, and after the 12th week of training or follow-up | |
Secondary | glucose | A fasting venous blood sample will be obtained immediately before and after the study for measurement of glucose. | at baseline, at the sixth week, and after the 12th week of training or follow-up | |
Secondary | Blood lipid | A fasting venous blood sample will be obtained immediately before and after the study for measurement of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides. | at baseline, at the sixth week, and after the 12th week of training or follow-up | |
Secondary | N-terminal pro-BNP | A fasting venous blood sample will be obtained immediately before and after the study for measurement of N-terminal pro-BNP. | at baseline, at the sixth week, and after the 12th week of training or follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04962178 -
Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset
|
N/A | |
Not yet recruiting |
NCT04549766 -
Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI
|
||
Not yet recruiting |
NCT05511831 -
The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
|
Phase 4 | |
Completed |
NCT05649696 -
Prolonged Clinical Follow-up of OPTIMA-5
|
Phase 4 | |
Recruiting |
NCT05506449 -
The RECOVER IV Trial
|
N/A | |
Completed |
NCT01144819 -
Platelet Inhibition in the Acute Phase of STEMI
|
N/A | |
Recruiting |
NCT03539133 -
Systemic Organ Communication in STEMI
|
||
Completed |
NCT01642667 -
Pharmacoinvasive Therapy With Prourokinase
|
Phase 2/Phase 3 | |
Completed |
NCT04131816 -
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
|
N/A | |
Recruiting |
NCT03768453 -
EARLY-MYO-CMR Registry
|
||
Completed |
NCT04942977 -
Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy
|
N/A | |
Recruiting |
NCT04912518 -
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
Completed |
NCT04996901 -
The Chinese STEMI PPCI Registry (CSPR)
|
||
Recruiting |
NCT05892042 -
Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
|
N/A | |
Completed |
NCT02197117 -
Effect of Remote Ischemic Conditioning in Heart Attack Patients
|
N/A | |
Completed |
NCT02733341 -
The Effect of IV Cangrelor and Oral Ticagrelor Study
|
Phase 4 | |
Not yet recruiting |
NCT04110691 -
Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
|
||
Recruiting |
NCT05510661 -
Use of Export in Primary Percutaneous Coronary Intervention
|
N/A | |
Recruiting |
NCT05709626 -
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
|
Phase 4 | |
Recruiting |
NCT05046483 -
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
|